Literature DB >> 14500683

S epsilon S mu and S epsilon S gamma switch circles in human nasal mucosa following ex vivo allergen challenge: evidence for direct as well as sequential class switch recombination.

Lisa Cameron1, Abdelilah Soussi Gounni, Saul Frenkiel, François Lavigne, Donata Vercelli, Qutayba Hamid.   

Abstract

B cells switch to IgE under the influence of IL-4, IL-13, and CD40 costimulation through a multistep process involving epsilon germline transcription and class switch recombination. Classically, switching has been considered an event restricted to lymphoid tissues; however, epsilon germline transcripts (I(initiator)epsilon RNA) have been observed within lung, sinus, and nasal tissue of individuals with asthma, sinusitis, and rhinitis. Furthermore, nasal mucosal tissue from allergic rhinitics produces epsilon germline transcripts following ex vivo allergen challenge. Collectively, these studies raised the possibility that switching to IgE may occur locally, at sites of allergic inflammation. Although epsilon germline transcripts are considered necessary to target the IgE locus, it is class switch recombination that ultimately leads to de novo IgE production. In this study, we demonstrate that S epsilon S mu DNA switch circles (products of class switch recombination) as well as I epsilon and C epsilon RNA are produced within nasal tissue from allergic individuals following ex vivo allergen challenge. epsilon germline transcription was inhibited when tissue was cultured with a combination of allergen and neutralizing Abs against IL-4 and IL-13, indicating that de novo cytokine production mediated the isotype switch. We also show allergen-induced appearance of S epsilon S gamma DNA switch circles and up-regulation of C gamma 4 mRNA, illustrating that sequential switching to IgE also occurred. This work strongly suggests that B cells residing within the nasal mucosa undergo switching to IgE in the context of a local immune response to allergen.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14500683     DOI: 10.4049/jimmunol.171.7.3816

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  33 in total

1.  Alterations on peripheral blood B cell subsets induced by allergic rhinitis.

Authors:  Ana Henriques; Rodrigo Nunes; Graça Loureiro; António Martinho; Maria Pais; António Segorbe-Luís; Hélder Trindade; Celso Pereira; Artur Paiva
Journal:  Inflamm Res       Date:  2015-02-21       Impact factor: 4.575

Review 2.  The role of the T follicular helper cells in allergic disease.

Authors:  D M Kemeny
Journal:  Cell Mol Immunol       Date:  2012-08-20       Impact factor: 11.530

3.  International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis.

Authors:  Sarah K Wise; Sandra Y Lin; Elina Toskala; Richard R Orlandi; Cezmi A Akdis; Jeremiah A Alt; Antoine Azar; Fuad M Baroody; Claus Bachert; G Walter Canonica; Thomas Chacko; Cemal Cingi; Giorgio Ciprandi; Jacquelynne Corey; Linda S Cox; Peter Socrates Creticos; Adnan Custovic; Cecelia Damask; Adam DeConde; John M DelGaudio; Charles S Ebert; Jean Anderson Eloy; Carrie E Flanagan; Wytske J Fokkens; Christine Franzese; Jan Gosepath; Ashleigh Halderman; Robert G Hamilton; Hans Jürgen Hoffman; Jens M Hohlfeld; Steven M Houser; Peter H Hwang; Cristoforo Incorvaia; Deborah Jarvis; Ayesha N Khalid; Maritta Kilpeläinen; Todd T Kingdom; Helene Krouse; Desiree Larenas-Linnemann; Adrienne M Laury; Stella E Lee; Joshua M Levy; Amber U Luong; Bradley F Marple; Edward D McCoul; K Christopher McMains; Erik Melén; James W Mims; Gianna Moscato; Joaquim Mullol; Harold S Nelson; Monica Patadia; Ruby Pawankar; Oliver Pfaar; Michael P Platt; William Reisacher; Carmen Rondón; Luke Rudmik; Matthew Ryan; Joaquin Sastre; Rodney J Schlosser; Russell A Settipane; Hemant P Sharma; Aziz Sheikh; Timothy L Smith; Pongsakorn Tantilipikorn; Jody R Tversky; Maria C Veling; De Yun Wang; Marit Westman; Magnus Wickman; Mark Zacharek
Journal:  Int Forum Allergy Rhinol       Date:  2018-02       Impact factor: 3.858

Review 4.  IgE Test in Secretions of Patients with Respiratory Allergy.

Authors:  Carmen Rondón; Ibon Eguíluz-Gracia; Mohamed H Shamji; Janice A Layhadi; María Salas; María José Torres; Paloma Campo
Journal:  Curr Allergy Asthma Rep       Date:  2018-10-13       Impact factor: 4.806

5.  [Local allergic rhinitis to Alternaria alternata : Evidence for local IgE production exclusively in the nasal mucosa].

Authors:  L Klimek; C Bardenhewer; M Spielhaupter; C Harai; K Becker; O Pfaar
Journal:  HNO       Date:  2015-05       Impact factor: 1.284

6.  B-cell agonists up-regulate AID and APOBEC3G deaminases, which induce IgA and IgG class antibodies and anti-viral function.

Authors:  Thomas Seidl; Trevor Whittall; Kaboutar Babaahmady; Thomas Lehner
Journal:  Immunology       Date:  2012-03       Impact factor: 7.397

Review 7.  [Local (exclusive) IgE production in the nasal mucosa. Evidence for local allergic rhinitis].

Authors:  L Klimek; L von Bernus; O Pfaar
Journal:  HNO       Date:  2013-03       Impact factor: 1.284

8.  Chronic rhinosinusitis with nasal polyps is characterized by B-cell inflammation and EBV-induced protein 2 expression.

Authors:  Kathryn E Hulse; James E Norton; Lydia Suh; Qiu Zhong; Mahboobeh Mahdavinia; Patrick Simon; Robert C Kern; David B Conley; Rakesh K Chandra; Bruce K Tan; Anju T Peters; Leslie C Grammer; Kathleen E Harris; Roderick G Carter; Atsushi Kato; Robert P Schleimer
Journal:  J Allergy Clin Immunol       Date:  2013-03-06       Impact factor: 10.793

9.  Isolation and phenotypic characterization of mucosal nasal lymphocytes by direct ex vivo analysis.

Authors:  Christin Wolfram; Claudia Rasche; Heike Audring; Michael Wahls; Margitta Worm
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-09-03       Impact factor: 2.503

10.  Human B-cell isotype switching origins of IgE.

Authors:  Timothy J Looney; Ji-Yeun Lee; Krishna M Roskin; Ramona A Hoh; Jasmine King; Jacob Glanville; Yi Liu; Tho D Pham; Cornelia L Dekker; Mark M Davis; Scott D Boyd
Journal:  J Allergy Clin Immunol       Date:  2015-08-22       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.